L PERRIGO CO FDA Approval ANDA 075232

ANDA 075232

L PERRIGO CO

FDA Drug Application

Application #075232

Documents

Label2000-01-06
Letter2000-01-06
Review2001-12-28

Application Sponsors

ANDA 075232L PERRIGO CO

Marketing Status

Over-the-counter001

Application Products

001TABLET;ORAL2MG0LOPERAMIDE HYDROCHLORIDELOPERAMIDE HYDROCHLORIDE

FDA Submissions

ORIG1AP2000-01-06
MANUF (CMC); Manufacturing (CMC)SUPPL2AP2002-10-04
MANUF (CMC); Manufacturing (CMC)SUPPL3AP2002-10-04
LABELING; LabelingSUPPL4AP2002-10-04
MANUF (CMC); Manufacturing (CMC)SUPPL5AP2002-10-04
LABELING; LabelingSUPPL6AP2002-10-04
LABELING; LabelingSUPPL20AP2007-10-23
LABELING; LabelingSUPPL44AP2020-06-08STANDARD
LABELING; LabelingSUPPL46AP2020-06-08STANDARD

Submissions Property Types

SUPPL1Null0
SUPPL2Null0
SUPPL3Null0
SUPPL5Null0
SUPPL44Null15
SUPPL46Null15

CDER Filings

L PERRIGO CO
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 75232
            [companyName] => L PERRIGO CO
            [docInserts] => ["",""]
            [products] => [{"drugName":"LOPERAMIDE HYDROCHLORIDE","activeIngredients":"LOPERAMIDE HYDROCHLORIDE","strength":"2MG","dosageForm":"TABLET;ORAL","marketingStatus":"Over-the-counter","te":"None","rld":"No","rs":"No"}]
            [labels] => [{"actionDate":"01\/06\/2000","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/anda\\\/2000\\\/75-232_Loperamide_prntlbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"LOPERAMIDE HYDROCHLORIDE","submission":"LOPERAMIDE HYDROCHLORIDE","actionType":"2MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Over-the-counter","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 2000-01-06
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.